ישראל -
עברית -
Ministry of Health
ioptimate (cat. no. ass-35-102)
ioptima ltd. - רופא - the ioptimate™ laser beam manipulating system is intended to deliver a co2 laser beam for ablation of scleral soft tissue. the system is indicated for use in the non-penetrating deep sclerectomy procedure.
ישראל -
עברית -
Ministry of Health
optical vision screener titmus 2a
מדי פישר הנדסה ומדע (2002) בע"מ - אחות - מיכשור לבדיקות עיניים
ישראל -
עברית -
Ministry of Health
airtraq-optical laryngoscope
עמוס גזית בע"מ - רופא - לרינגוסקופ אופטי עם תעלת טובוס
ישראל -
עברית -
Ministry of Health
optical coherent tomography technology
מדפוינט טכנולוגיות בע"מ - רופא - מערכת הדמיה תוך עורקית
ישראל -
עברית -
Ministry of Health
optical coherent tomography (oct) lightlab/sjm imaging system & accessories
גאמידה בע"מ - רופא - הדמיית כלי דם לשם אבחון וטיפול בצנתורים
ישראל -
עברית -
Ministry of Health
optispray surgical spray device
סלע מדיקל בע"מ - רופא - atomize solutions used during open and laparoscopic surgical procedures
ישראל -
עברית -
Ministry of Health
"optima iud tcu 380a, iud tcu 380s with steriload* applicator"
"דין ציוד רפואי בע""מ" - רופא
ישראל -
עברית -
Ministry of Health
פגסיס 135 מק"ג/0.5 מ"ל
roche pharmaceuticals (israel) ltd - peginterferon alfa 2a 135 mcg / 0.5 ml - solution for injection - peginterferon alfa-2a - chronic hepatitis b: pegasys is indicated for the treatment of both hbeag- positive and hbeag -negative chronic hepatitis b in non-cirrhotic and cirrhotic adult patients with compensated liver disease and evidence of viral replication and liver inflammation.chronic hepatitis c: pegasys is indicated for the treatment of chronic hepatitis c in adult patients who are positive for serum hcv-rna including patients with compensated cirrhosis and/or co-infected with clinically stable hiv. the optimal way to use pegasys in patients with chronic hepatitis c is in combination with ribavirin. the combination of pegasys and ribavirin is indicated in naive patients and patients who have failed previous treatment with interferon alpha (pegylated or non-pegylated ) alone or in combination therapy with ribavirin. monotherapy is indicated mainly in case of intolerance or contraindication to ribavirin.
ישראל -
עברית -
Ministry of Health
פגסיס 180 מק"ג/0.5 מ"ל
roche pharmaceuticals (israel) ltd - peginterferon alfa 2a 180 mcg / 0.5 ml - solution for injection - peginterferon alfa-2a - chronic hepatitis b: pegasys is indicated for the treatment of both hbeag- positive and hbeag -negative chronic hepatitis b in non-cirrhotic and cirrhotic adult patients with compensated liver disease and evidence of viral replication and liver inflammation.chronic hepatitis c: pegasys is indicated for the treatment of chronic hepatitis c in adult patients who are positive for serum hcv-rna including patients with compensated cirrhosis and/or co-infected with clinically stable hiv. the optimal way to use pegasys in patients with chronic hepatitis c is in combination with ribavirin. the combination of pegasys and ribavirin is indicated in naive patients and patients who have failed previous treatment with interferon alpha (pegylated or non-pegylated ) alone or in combination therapy with ribavirin. monotherapy is indicated mainly in case of intolerance or contraindication to ribavirin.